Inhibikase Therapeutics IKT
NASDAQ IKT
$1.59 -0.04 (-2.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Net Shares Issued and Repurchased (2020 - 2026)

Updated

Analysis

Inhibikase Therapeutics (IKT) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -9.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Inhibikase Therapeutics 278.44 Mn -307.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.90 Mn
Dec 31, 2025 108.18 Mn
Sep 30, 2025 250,932.00
Jun 30, 2025 31,771.00
Dec 31, 2024 99.68 Mn
Sep 30, 2024 181,954.00
Jun 30, 2024 3.21 Mn
Mar 31, 2024 397,607.00
Dec 31, 2023 452.00
Sep 30, 2023 70.00
Jun 30, 2023 7.54 Mn
Mar 31, 2023 1.00 Mn
Mar 31, 2022 44,142.00
Sep 30, 2021 29,892.00
Jun 30, 2021 41.18 Mn
Dec 31, 2020 14.79 Mn
Sep 30, 2020 -67,132.00
Mar 31, 2020 4,870.00
API Access

Inhibikase Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=IKT&period=max&api_key=YOUR_API_KEY